Inventor profile of:

Roy E. TWYMAN

City:

Doylestown, Pennsylvania

Country:

United States

Published Applications:

17

Last publication date:

2025-09-18

Top Assignees for applications by Roy E. TWYMAN

The entities that hold a legal rights for patent applications filed by inventor TWYMAN Roy E.:

Recent patent applications by TWYMAN Roy E.

Roy E. TWYMAN from Doylestown, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-18
US20250288584A1
Human necessities

COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE

#2 | 2025-02-06
US20250041301A1
Human necessities

COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE

#3 | 2022-05-12
US20220143141A1
Human necessities

COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE

#4 | 2022-02-17
US20220047593A1
Human necessities

Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

#5 | 2020-05-07
US20200138814A1
Human necessities

Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

#6 | 2020-05-07
US20200138813A1
Human necessities

Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

#7 | 2016-12-22
US20160367554A1
Human necessities

Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

#8 | 2011-06-23
US20110152362A1
Human necessities

METHODS OF TREATING EPILEPTOGENESIS AND EPILEPSY

#9 | 2009-09-17
US20090234003A1
Human necessities

CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING ANXIETY DISORDERS

#10 | 2009-05-28
US20090137652A1
Human necessities

METHODS FOR NEUROPROTECTION

#11 | 2009-01-01
US20090005442A1
Human necessities

CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING NEURODEGENERATIVE DISORDERS

#12 | 2007-01-25
US20070021501A1
Human necessities

Methods of treating epileptogenesis

#13 | 2007-01-25
US20070021500A1
Human necessities

Methods for neuroprotection

#14 | 2006-10-17
US10081606
-

Carbamate compounds for use in preventing or treating bipolar disorder

#15 | 2006-08-31
US20060194873A1
Human necessities

Methods of treating epileptogenesis and epilepsy

#16 | 2006-07-18
US10081713
-

Carbamate compounds for use in preventing or treating anxiety disorders

#17 | 2005-12-01
US20050267203A1
Human necessities

Carbamate compounds for use in preventing or treating anxiety disorders

InventorID:

1740980 ⎘